N-((R)-4-(2-(3-cyano-4-isopropoxyphenyl)thiazol-5-yl)-2,3-dihydro-1H-inden-1-yl)-2-((R)-3-hydroxypiperidin-1-yl)ethanesulfonamide | 1307869-80-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: N-((R)-4-(2-(3-cyano-4-isopropoxyphenyl)thiazol-5-yl)-2,3-dihydro-1H-inden-1-yl)-2-((R)-3-hydroxypiperidin-1-yl)ethanesulfonamide
• 英文别名: N-[(1R)-4-[2-(3-cyano-4-propan-2-yloxyphenyl)-1,3-thiazol-5-yl]-2,3-dihydro-1H-inden-1-yl]-2-[(3R)-3-hydroxypiperidin-1-yl]ethanesulfonamide
• CAS: 1307869-80-2
• 化学式: C₂₉H₃₄N₄O₄S₂
• 分子量: 566.745
• InChiKey: QHHMAJXXQFMRRD-ATIYNZHBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  39
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  152
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  (R)-N-(4-(2-(3-cyano-4-isopropoxyphenyl)thiazol-5-yl)-2,3-dihydro-1H-inden-1-yl)ethenesulfonamide 、 (R)-(+)-3-羟基哌啶盐酸盐 以 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 以to give 10 mg (80%) of N—((R)-4-(2-(3-cyano-4-isopropoxyphenyl)thiazol-5-yl)-2,3-dihydro-1H-inden-1-yl)-2-((R)-3-hydroxypiperidin-1-yl)ethanesulfonamide 143的产率得到N-((R)-4-(2-(3-cyano-4-isopropoxyphenyl)thiazol-5-yl)-2,3-dihydro-1H-inden-1-yl)-2-((R)-3-hydroxypiperidin-1-yl)ethanesulfonamide
  参考文献：
  名称：

  SELECTIVE HETEROCYCLIC SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS

  摘要：

  提供了选择性调节鞘氨醇1磷酸受体的化合物，包括调节S1P受体亚型1的化合物。提供了这种化合物的手性合成方法。与调节鞘氨醇1磷酸受体在医学上指示的疾病，异常状态和障碍的治疗或预防有关，提供了使用，治疗或预防的方法以及包括创新化合物的创新组合物的制备方法。

  公开号：

  US20150252037A1

文献信息

• Selective heterocyclic sphingosine 1 phosphate receptor modulators
  申请人：Boehm Marcus F.

  公开号：US08507538B2

  公开（公告）日：2013-08-13

  Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.

  提供了选择性调节鞘氨醇1磷酸受体的化合物，包括调节S1P受体亚型1的化合物。提供了这种化合物的手性合成方法。在与医学上需要调节鞘氨醇1磷酸受体的疾病、异常状态和障碍的治疗或预防方面，提供了使用、治疗或预防方法和准备创新组合物的方法，包括创新化合物。
• US8507538B2
  申请人：——

  公开号：US8507538B2

  公开（公告）日：2013-08-13
• US9481659B2
  申请人：——

  公开号：US9481659B2

  公开（公告）日：2016-11-01
• [EN] SELECTIVE HETEROCYCLIC SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS<br/>[FR] MODULATEURS DE RÉCEPTEUR DE SPHINGOSINE-1-PHOSPHATE HÉTÉROCYCLIQUES SÉLECTIFS
  申请人：RECEPTOS INC

  公开号：WO2011060391A1

  公开（公告）日：2011-05-19

  Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the SlP receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.
• [EN] SELECTIVE HETEROCYCLIC SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS<br/>[FR] MODULATEURS HÉTÉROCYCLIQUES SÉLECTIFS DU RÉCEPTEUR DE LA SPHINGOSINE-1-PHOSPHATE
  申请人：RECEPTOS INC

  公开号：WO2012158550A2

  公开（公告）日：2012-11-22

  Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds is provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.